Trial Profile

Phase II/III study of Fosbretabulin in patients with Glioblastoma multiforme

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 05 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fosbretabulin (Primary)
Indications Glioblastoma
Focus Therapeutic Use

Most Recent Events

03 Feb 2016 According to an Oxigene media release, the company will not initiate this study in 2016 because most of their current efforts for developing CA4P will be on FOCUS (see CT profile 700257531).
01 Oct 2015 New trial record
29 Sep 2015 According to Oxigene media release, company is planning to initiate this trial in the second half of 2016.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com